Our research has revealed that KPNA2 is significantly overexpressed in lung adenocarcinoma tissues, and that patients with elevated levels of KPNA2 expression typically have poorer survival outcomes, which is consistent with the findings of previous studies. This evidence concerns the gene KPNA2 and lung adenocarcinoma.